· 42% of migraine sufferers are not satisfied with their prescribed treatment
· 9 in 10 say the condition has a negative impact on their quality of life
· Migraine is the third most prevalent disease in the world with more than 1 billion people suffering worldwide
Those who are fortunate enough not to suffer with migraines may be quick enough to dismiss them as ‘just a headache’, a minor grievance or even an overreaction from those who suffer with them. However, nine in ten people who experience migraines feel that it has an overall negative impact on their quality of life, while 60% believe it affects their social life, studies and work.
That is according to Teva, who along with the European Migraine and Headache Alliance (EMHA), is calling on healthcare professionals to support timely diagnosis and treatment for migraine sufferers.
While 77% of people who suffer with migraines believe their doctor takes the condition very seriously, 30% doubt that they are sufficiently informed on the latest treatments. Furthermore, 42% are not satisfied with their prescribed medicine and one in four want to be more involved in deciding their course of treatment.
Migraine is a disabling neurological disease that causes recurrent episodes of pain lasting between 4 and 72 hours. Symptoms include severe head pain, nausea, vomiting, photophobia (sensitivity to light), phonophobia (sensitivity to sound), and changes in vision. It affects more than one billion people worldwide, which makes it the third most prevalent disease in the world.
Effective prevention and management requires continuous assessment and treatment evaluation by a healthcare professional. In many cases, preventative treatment can not only reduce frequency, but also the risk of its progression to a more severe disease.